DEBRISOQUIN SULFATE

Suppliers

Names

[ CAS No. ]:
581-88-4

[ Name ]:
DEBRISOQUIN SULFATE

[Synonym ]:
2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1)
Debrisoquin hemisulfate
Bis[3,4-dihydroisoquinolin-2(1H)-yl(imino)methanaminium] sulfate
debrisoquine sulfate
3,4-Dihydroisoquinoline-2(1H)-carboximidamide sulfate (2:1)
3,4-Dihydro-2(1H)-isoquinolinecarboximidamide sulfate (2:1)
Debrisoquin sulfate
debrisoquine sulphate

Chemical & Physical Properties

[ Boiling Point ]:
309.8ºC at 760 mmHg

[ Melting Point ]:
278-280°, 284-285° or 266-268° (H2O)

[ Molecular Formula ]:
C10H13N3.1/2H2O4S

[ Molecular Weight ]:
224.27

[ Flash Point ]:
141.1ºC

[ Exact Mass ]:
448.189270

[ PSA ]:
189.20000

[ LogP ]:
3.78020

[ Storage condition ]:
-20°C Freezer

[ Water Solubility ]:
H2O: 20 mg/mL with heat

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NW7010000
CAS REGISTRY NUMBER :
581-88-4
LAST UPDATED :
198804
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C10-H13-N3.1/2H2-O4-S
MOLECULAR WEIGHT :
224.30
WISWESSER LINE NOTATION :
T66 CNT&J CYZUM & 2WSQQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
610 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation) Lungs, Thorax, or Respiration - respiratory depression Nutritional and Gross Metabolic - body temperature decrease
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 17,129,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
235 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CTCEA9 Current Therapeutic Research, Clinical & Experimental. (Therapeutic Research Press, Inc., POB 514, Tenafly, NJ 07670) V.1- 1959- Volume(issue)/page/year: 6,299,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
132 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CTCEA9 Current Therapeutic Research, Clinical & Experimental. (Therapeutic Research Press, Inc., POB 514, Tenafly, NJ 07670) V.1- 1959- Volume(issue)/page/year: 6,299,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
136 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CTCEA9 Current Therapeutic Research, Clinical & Experimental. (Therapeutic Research Press, Inc., POB 514, Tenafly, NJ 07670) V.1- 1959- Volume(issue)/page/year: 6,299,1964
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
31700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CTCEA9 Current Therapeutic Research, Clinical & Experimental. (Therapeutic Research Press, Inc., POB 514, Tenafly, NJ 07670) V.1- 1959- Volume(issue)/page/year: 6,299,1964

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
22

[ Safety Phrases ]:
26-36

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
NW7010000

[ HS Code ]:
2933499090

Customs

[ HS Code ]: 2933499090

[ Summary ]:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.

BMC Genomics 16 Suppl 1 , S1, (2015)

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths worldwide with less than a 6% 5-year survival rate. PDAC is associated with poor prognosis based on the late stage ...

A Comprehensive Metabolomic Investigation in Urine of Mice Exposed to Strontium-90.

Radiat. Res. 183 , 665-74, (2015)

Internal emitters such as Strontium-90 ((90)Sr) pose a substantial health risk during and immediately after a nuclear disaster or detonation of an improvised device. The environmental persistency and ...

Global Metabolomic Identification of Long-Term Dose-Dependent Urinary Biomarkers in Nonhuman Primates Exposed to Ionizing Radiation.

Radiat. Res. 184 , 121-33, (2015)

Due to concerns surrounding potential large-scale radiological events, there is a need to determine robust radiation signatures for the rapid identification of exposed individuals, which can then be u...


More Articles


Related Compounds

  • Debrisoquin-13C,15N2 Hemisulfate
  • Debrisoquin hydriodide
  • diethyl sulfate,N,N-dimethylformamide
  • GUANINE SULFATE
  • hydrogen sulfate,3-methoxy-4-methoxycarbonylbenzenediazonium
  • Testosterone Sulfate Triethylamine Salt
  • 2-Bromo-5-(difluoromethyl)-4-nitronicotinamide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 2-(4-(2,6-Dichlorophenyl)-5-hydroxy-1H-indol-3-yl)acetonitrile
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 1-(5-Amino-2-(methylthio)phenyl)-3-chloropropan-1-one
  • 2-(3-Bromo-4-methylphenyl)-2-oxoacetic acid
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide